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KEYWORDS Summary We describe a case of a young patient with a recurrent episode of very late stent
thrombosis (VLST) in whom the sirolimus-eluting stent was implanted on the culprit lesion inVery late stent
thrombosis;
Sirolimus-eluting
stent
the left anterior descending artery. The present case showed when the etiology of VLST was not
clear or in doubt of stent fracture, vigorous investigation for other causes using high resolution
technology such as intravascular ultrasound or computed tomography angiography might be
helpful for prevention of catastrophic events such as VLST.
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ery late stent thrombosis (VLST), which represents a life-
hreatening event, has been raised as a safety concern
ssociated with drug-eluting stents (DES). It is usually trig-
ered by inadequate antiplatelet therapy and promoted by
ultiple risk factors, such as presence of multiple or long
tents, an abnormal vascular response to the DES, stent
alapposition, and stent fracture (SF) [1—5]. In some cases,
owever, the underlying mechanism is not clearly deﬁned.
e describe a case of a young patient with a recurrent
∗ Corresponding author. Tel.: +82 32 460 3054;
ax: +82 32 469 1906.
E-mail address: kangwch@gilhospital.com (W.C. Kang).
t
b
e
p
E
s
n
L
878-5409/$ — see front matter © 2011 Japanese College of Cardiology.
oi:10.1016/j.jccase.2011.10.007diology. Published by Elsevier Ltd. All rights reserved.
pisode of VLST in whom the sirolimus-eluting stent (SES)
as implanted on the culprit lesion in the left anterior
escending (LAD) artery during primary percutaneous coro-
ary intervention (PCI).
ase report
31-year-old male came to our emergency room (ER) due
o severe constrictive chest pain. He was a heavy smoker
ut other cardiovascular risk factors were absent. Initial
lectrocardiogram (ECG) showed elevated ST segment at
recordial leads and all biomarkers were markedly elevated.
chocardiography showed hypokinesia of anterior wall and
eptum from base to mid left ventricle. Emergency coro-
ary angiography demonstrated subtotal occlusion of mid
AD and diagonal artery (Fig. 1A). After pre-dilatation, SES
Published by Elsevier Ltd. All rights reserved.
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Figure 1 On ﬁrst admission, coronary angiography demonstrated subtotal occlusion of mid left anterior descending artery (LAD)
(open arrow) and diagonal artery (A). After pre-dilatation, sirolimus-eluting stent (2.75mm× 28mm) was deployed successfully at
LAD lesion and balloon dilatation was performed at diagonal artery. Final angiography showed good distal ﬂow (B). On second admis-
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Dsion, coronary angiography showed complete occlusion (white a
After continuous infusion of glycoprotein IIb—IIIa inhibitor and b
(CypherTM 2.75mm× 28mm; Cordis, Bridgewater, NJ, USA)
was deployed successfully at the LAD lesion and balloon
dilatation was performed at diagonal artery. Final angiog-
raphy showed good distal ﬂow without residual stenosis or
dissection at the lesion (Fig. 1B). Five days after PCI, the
patient was discharged with medication including aspirin
100mg/day and clopidogrel 75mg/day.
He remained symptom-free until he revisited our ER again
due to chest pain 2 years after the PCI had been performed.
He had been taking medication including aspirin and clopido-
grel. ECG showed elevated ST segment at precordial leads.
Emergency coronary angiography showed complete occlu-
sion of previous DES with thrombus atmid LAD (Fig. 1C). Even
after repeated balloon dilatation, the ﬂow was not restored
due to huge amount of thrombosis. After continuous infusion
of glycoprotein IIb—IIIa inhibitor, coronary ﬂow was restored
without residual thrombosis (Fig. 1D) and triple antiplatelet
therapy (aspirin 100mg/day, clopidogrel 75mg/day, and
cilostazol 200mg/day) was started. Ten days after the sec-
ond PCI, the patient was discharged with triple antiplatelet
therapy. Triple antiplatelet therapy was maintained for one
and a half years and replaced by dual antiplatelet therapy
after that.
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a) of previous drug-eluting stent with thrombus at mid LAD (C).
n dilation, coronary ﬂow was restored without thrombosis (D).
Two and a half years after the second PCI, he revisited
ur ER again due to chest pain that developed on taking
ual antiplatelet drugs. ECG showed ST elevation in precor-
ial leads. Emergency coronary angiography showed total
cclusion of same site in the DES at mid LAD (Fig. 2A). Fur-
hermore, misalignment of stent, which is suggestive of SF,
as noted at the middle part of the stent (Fig. 2B). Intravas-
ular ultrasound (IVUS) investigation revealed complete
eparation of proximal and distal stent strut correspond-
ng to SF on angiography (Fig. 2C). After careful evaluation
f IVUS ﬁndings, the lesion was managed with an addi-
ional stent (Endeavor stent 2.75mm× 30mm; Medtronic,
inneapolis, MN, USA). Follow-up angiography showed good
istal ﬂow without residual stenosis or dissection (Fig. 2D).
inally, he was discharged with dual antiplatelets, remaining
symptomatic.
iscussionn the present case, the etiology of the ﬁrst episode of VLST
as not clear. He was taking dual antiplatelet continuously
fter the ﬁrst PCI. Several factors were found that may have
e10 S.Y. Suh et al.
Figure 2 Two and half years after the second percutaneous coronary intervention, he revisited our emergency room again due to
chest pain. Coronary angiography showed total occlusion of the same site in the previous drug-eluting stent (DES) at mid left anterior
descending artery (A). Furthermore, misalignment of stent, which is suggestive of stent fracture (SF), was noted at middle of stent
(dotted line, B). Intravascular ultrasound investigation revealed complete separation of proximal and distal stent strut corresponding
to SF on angiography (C). The lesion was treated with another DES (2.75mm× 30mm). Follow-up angiography showed good distal
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ontributed to the VLST: (1) suboptimal PCI technique; (2)
F; (3) markedly remodeled vessel with stent malapposition;
4) aspirin or clopidogrel resistance. But an IVUS study or test
or drug resistance was not performed at that time. The sub-
equent episode of VLST occurred despite triple antiplatelet
herapy with aspirin, clopidogrel, and cilostazol, due to SF
hich was conﬁrmed by IVUS study. Drug resistance test for
spirin and clopidogrel was negative. SF was managed with
dditional stenting because we thought the separation of
tent struts from the arterial wall might serve as a local
idus for thrombus formation.
A cluster of unfavorable factors as mentioned above
esulted in the life-threatening recurrent episode of the
LST. SF is known as one of possible prothrombotic risk
actors, frequently associated with aneurysms and malappo-
ition, occurring in particular with longer stents, overlapping
tents, angulated vessels, and hinge movements as in our
ase [6,7]. However, it is not easy to detect SF. Coro-
ary stents are minimally radiopaque and move constantly
uch that visualization requires an imaging modality with
ery high spatial and temporal resolution. Diagnosis of
d
h
m
aF mainly relies on coronary angiography or IVUS. Trehan
t al. described the triad needed for SF visualization with
ngiography: the fracture must be moderate to severe, the
tent must be reasonably radiopaque, and the patient can-
ot be too obese [8]. So grade I or II SF might not be
etected by coronary angiography. Compared to angiogra-
hy, IVUS appears to be of potential value for detection
f SF [9]. Computed tomography (CT) angiography also
howed the highest sensitivity and speciﬁcity in detecting
he SF, especially the longitudinal orientation of the fracture
10].
As described above, the etiology of the ﬁrst VLST was not
lear in the present case. Despite continuously taking med-
cation, the second VLST occurred after one and half years
ost-second PCI due to SF. There was a possibility that SF
ight have already predisposed to the ﬁrst VLST. The present
ase showed when the etiology of VLST was not clear or in
oubt of SF, vigorous investigation for another cause using
igh resolution technology such as IVUS or CT angiography
ight be helpful for prevention of catastrophic events such
s VLST.
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